Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Jacobio Pharmaceuticals Group Co., Ltd. ( (HK:1167) ) has provided an announcement.
Jacobio Pharmaceuticals Group Co., Ltd. has announced its 2025 Annual General Meeting, scheduled for June 10, 2025, in Beijing. The meeting will address several key resolutions, including the adoption of the 2024 financial statements, re-election of directors, and re-appointment of auditors. Additionally, the company seeks approval to allot and issue new shares, which could potentially expand its capital base and support future growth initiatives.
The most recent analyst rating on (HK:1167) stock is a Hold with a HK$3.70 price target. To see the full list of analyst forecasts on Jacobio Pharmaceuticals Group Co., Ltd. stock, see the HK:1167 Stock Forecast page.
More about Jacobio Pharmaceuticals Group Co., Ltd.
Jacobio Pharmaceuticals Group Co., Ltd. is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. The company focuses on the development and commercialization of innovative drugs, with a market emphasis on oncology treatments.
Average Trading Volume: 8,777,169
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.95B
For detailed information about 1167 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue